|
|
|
|
|
|
Investments on Propel(x) are high risk, illiquid and bear the risk of partial or complete loss of invested capital. Please review risk factors for investments on Propel(x) here.
This newsletter is for informational purposes only. It is not a solicitation to buy or sell a security.
|
|
|
|
|
|
|
|
|
We begin this newsletter with a few of our portfolio startups which have been in the news recently. If you are not on Propel(x) yet, we have provided a step
by step guide on how to create an accredited investor account on our platform. Creating an account is free. Sign up today!
Considering the buzz around alternatives in the current environment, we wrote a blog post on how investing in
commodities can be a potential hedge against inflation.
According to the National Venture Capital Association, venture funding in the U.S. reached a record $332.8 billion in 2021. However, only 2.3% of VC funding went to companies founded by women. Our content partner ranked the top 15 states with the most venture capital investments in woman-led startups using data from PitchBook. Additionally, we highlight the woman-led
startups which raised financing through Propel(x) including an exit.
Lastly, we had an educational webinar in early September on QSBS Tax Exemption which was well received. For those interested, you can still watch the webinar replay.
Enjoy the scroll down!
|
|
|
|
|
|
|
Immusoft*, a clinical-stage cell therapy company dedicated to improving the lives of patients with rare diseases, became the first to receive FDA approval to test B cell gene therapy in humans. The company recently announced that the U.S. Food and Drug Administration (FDA) has cleared the Investigational New Drug Application (IND) for ISP-001 in the treatment of MPS I. The open IND enables Immusoft to initiate a Phase 1 clinical study. Read more here.**
Sonavex*, a developer of an imaging technology designed to visualize and quantify critical data to detect anastomotic blood clots, has recently received FDA clearance for its technology that uses ultrasound imaging and deep learning to deliver blood flow data on demand. Read more here.**
Zeto*, a medical device startup that commercializes its FDA approved smart wearable electroencephalography (EEG) headset, has recently formed its partnership with Next Gen Neuro, a continuous and routine EEG monitoring company, to provide remote EEG monitoring services.. Read more here.**
Neocis*, manufacturer of Yomi® and the global leader in robot-assisted dental implant surgery, announced today that YomiPlan Go™, the newest robotic workflow enabled by the Yomi system, is now available to all customers. Read more here.**
TaskHuman*, an on-demand personal and professional coaching platform recently announced a partnership with Purdue University. Read more here.**
Disclaimer - All these startups are Propel(x) alumni companies. They were either listed or fundraised through the Propel(x) platform.
* These links are gated and you will need to create a free account or sign in to view detailed information on the startup. This includes existing investors, pitch deck, deal terms, management information and much more.
** These links are provided solely as a convenience to readers and they do not imply an affiliation, sponsorship, endorsement, approval, investigation, verification, or monitoring by Hubble Investments or any of its affiliates of the contents on such
third-party websites.
|
|
|
|
|
|
|
| How to create an accredited investor account on Propel(x)
|
|
|
|
|
|
|
|
|
Once you have done your research and considered important relevant factors such as your risk profile, time horizon, and investment objectives, and decided you want to join Propel(x) to explore the live deals, how do you proceed?
Here is a
step-by-step guide to create an accredited investor account on the Propel(x) platform.
|
|
|
|
|
|
|
|
|
|
|
How to invest in commodities as an accredited investor?
|
|
|
|
|
|
|
|
|
The terms commodities, futures, contracts, trades, and derivatives might sound complicated and may often be associated with big business and large Wall Street traders.
However, it is possible for Accredited Investors to access the world of commodities investing.
|
|
|
|
|
|
|
Woman-Led Companies That Raised Financing Through Propel(x)
|
|
|
|
|
|
|
|
|
We ranked the top 15 states with the most venture capital investments in woman-founded or co-founded startups using data from PitchBook.
States have been ranked based on the total amount of VC funding that went to startups founded by at least one woman since 2018 through July 31, 2022.
Woman-Led Companies that raised financing through Propel(x)
- Cover Financial (female co-founder) - San Francisco, CA
- Landsdowne Labs (female CEO) - Fairfield,
CT
- Aegis Life (female COO) - San Diego, CA
- Repurpose Compostables (female founder and CEO) - Los Angeles, CA
- Blumio (female co-founder and CEO) - San Francisco, CA
- Insight Finder (female co-founder) - New York
- Torigen (female
founder and CEO) - Farmington, CT
Woman-Led Companies that raised financing through Propel(x) and had an exit
- zPredicta (female founder and CEO) - San Jose, CA
|
|
|
|
|
|
|
|
|
|
|
Did you know that when an individual receives stock in the company—whether it is a founder who gets founder stock, an employee who exercises stock options, or an investor who purchases preferred stock, they may potentially eliminate tax on all or a large portion of their gain when they sell. Many startup founders who are unaware of the existence and benefits of QSBS may be missing out on potential savings.
While startup equity can qualify for long-term capital gains, certain rules allow investors to go a step further and can qualify for an even more preferential U.S. tax treatment e.g. potentially up to 100% tax-free gains subject to certain conditions.
We hosted a panel discussion where we discussed the golden circle model – what, how and why of QSBS Tax Exemption for both investors and founders.
|
|
|
|
|
|
|
|
|
Our investor community is growing, we want to thank you for your support and participation. As always, we are happy to answer any questions or provide any support you need during your investing journey.
Tell the world that you are one of us! To show off being a member of Propel(x), we have included an animation below which shares how to associate yourself as an Investor with Propel(x) on LinkedIn.
|
|
|
|
|
|
|
|
|
|
|
|
|
Propel(x) is a digital alternative
investment platform that enables accredited investors to invest in startups and venture capital funds. Our customers range from individual accredited investors writing checks as small as $5,000 to some of the largest family offices and funds writing checks of a million dollars or more.
|
|
|
Investments on Propel(x) are high risk, illiquid and bear the risk of partial or complete loss of invested capital. Please review risk factors for investments on Propel(x) here.
|
|
|
|
|
|
|
|
|
